Special Programme on Human Reproduction: Difference between revisions

Revision as of 15:49, 13 March 2023

Revision as of 18:17, 13 March 2023

Line 31:

==Evolution to a Co-sponsored Special Programme==

In 1986, the structure of the Programme changed.<ref>{{Cite web|url=https://apps.who.int/iris/bitstream/handle/10665/120636/em_rc33_13_en.pdf?sequence=1&isAllowed=y|title=World Health Organization: EM/RC33/13 - Nomination of a member state to the Policy and Coordination advisory committee (PCAC) of the Special programme of research, development, and research training in human reproduction (HRP), July 1986|hdl=10665/120636 }}</ref> The advisory Group was replaced by the Policy and Coordination Advisory Committee (PCAC), a consultative organ to the Director-General which made recommendations on issues linked to the policies, funding and general organization of the programme. It was composed of 30 members, twelve being the countries that contributed the most, twelve elected by the regional committees, three elected by the PCAC itself and the [[UNFPA]], [[World Bank]] and [[International Planned Parenthood Federation|IPPF]] as permanent members. The new structure also included the Scientific and Technical Advisory Group (STAG)<ref name=sponso>{{Cite web|url=https://apps.who.int/iris/bitstream/handle/10665/162389/EB81_22_eng.pdf?sequence=1&isAllowed=y|title=RECENT DEVELOPMENTS IN HUMAN REPRODUCTION RESEARCH - Progress report by the Director-General |hdl=10665/162389 }}</ref>: composed of 10 to 15 members (experts and scientists) it designated the Programme research priorities, the creation or end of a task Force, and gave an independent evaluation of all scientific and technical aspect of the Programme.

In 1988, the co-sponsorship of the Programme began<ref name=sponso />: the [[UNDP]], [[UNFP]], [[World Bank]] and the [[WHO]] were co-sponsors of the "UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction", commonly referred to as "the HRP". This had to objective to obtain consequent and stable funding for the Programme. The PCAC became the Policy and Coordination Committee (PCC), in charge of the administration, the approval of the budget, and the general orientation of the work of the Programme and included the co-sponsors as permanent members. A Standing Committee, composed of representatives of the co-sponsors meets thrice a year, monitors the Programme situation and formulates recommendations to the PCC. As the executive agency, the WHO nominates the director of the Programme and other non-elected members of the HRP after consulting the Standing Committee. The STAG had also now to report to the Standing Committee while the Review Group is replaced by the Research Project Review Panel which had similar attributions, but includes also the control of the financial aspect of the research projects.